Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.33
-0.24 (-1.06%)
At close: Jul 19, 2024, 4:00 PM
23.30
+0.97 (4.34%)
Pre-market: Jul 22, 2024, 6:53 AM EDT
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for BCYC stock have an average target of 47.25, with a low estimate of 32 and a high estimate of 65. The average target predicts an increase of 111.60% from the current stock price of 22.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 3, 2024.
Analyst Ratings
The average analyst rating for BCYC stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +146.31% | May 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +92.57% | Apr 10, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +168.70% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +146.31% | Feb 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +92.57% | Feb 21, 2024 |
Financial Forecast
Revenue This Year
39.22M
from 26.98M
Increased by 45.38%
Revenue Next Year
29.47M
from 39.22M
Decreased by -24.87%
EPS This Year
-4.50
from -5.08
EPS Next Year
-5.19
from -4.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 59.3M | 57.8M | 110.2M | 210.0M | 462.0M |
| Avg | 39.2M | 29.5M | 44.1M | 124.7M | 332.4M |
| Low | 29.4M | n/a | n/a | 41.3M | 75.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 119.9% | 47.3% | 273.8% | 375.7% | 270.6% |
| Avg | 45.4% | -24.9% | 49.8% | 182.4% | 166.6% |
| Low | 9.0% | - | - | -6.5% | -39.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.66 | -4.28 | -4.32 | -3.92 | 1.69 |
| Avg | -4.50 | -5.19 | -5.30 | -4.63 | -1.15 |
| Low | -5.21 | -6.46 | -6.84 | -6.60 | -4.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.